#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombotic thrombocytopenic purpura Stress cardiomyopathy Paroxysmal nocturnal haemoglobinuria Hypoxic-ischaemic encephalopathy Biotinidase deficiency Germ cell cancer Lennox-Gastaut syndrome Familial hypertriglyceridaemia Haemophilia A with anti factor VIII Deafness bilateral Deafness neurosensory Rhabdomyosarcoma Dementia with Lewy bodies Hepatic angiosarcoma ROHHAD syndrome More trials…

    Learn about Rare Diseases

    Hereditary hypophosphataemic rickets – Basic Information X-linked lymphoproliferative syndrome – Basic Information Hepatic angiosarcoma – Treatment Von Willebrand’s disease – Life with Disease Factor VIII deficiency Myelodysplastic syndrome – Basic Information Glycogen storage disease type I – Diagnostics Mantle cell lymphoma stage IV – Treatment Castleman’s disease – Basic Information IgA nephropathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Egl-001 Ergocalciferol Nusinersen Mva-Hbvac Imifoplatin Ixekizumab Amb-05X ANGIOTENSIN II Vibozilimod Indometacin Ph. Eur. Epinephrine Xp-Dc+Tl+Klh Apocynin Belzupacap Sarotalocan Calcium Chloride Dihydrate Vidofludimus Calcium Art0380 Mesilate Nedosiran Vimseltinib Calcium Carbonate More therapies…

    Learn about Your Condition

    Glucose tolerance impaired Epithelioid sarcoma Post procedural infection Spinal cord injury cervical Pyoderma gangrenosum Renal cancer stage IV Arthritis infective Arterial disorder Fibrosarcoma metastatic Spina bifida Medulloblastoma recurrent Adenocarcinoma gastric Primary hyperaldosteronism Cardiac sarcoidosis Hot flush More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Brain neoplasm

  • Study of Tarlatamab and Temozolomide combination treatment in adolescents and adults with high grade brain tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    Investigated Drugs:
    • Tarlatamab
    • Temozolomide
    France

  • Study on Antibiotics Amoxicillin, Clavulanic Acid, Ciprofloxacin, and Drug Combination for Children with Malignant Brain Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    Investigated Drugs:
    • Cefotaxime Sodium
    • Cefuroxime Sodium
    • Gentamicin
    Austria

  • Study on Lithium Sulphate to Prevent Cognitive Impairment in Children After Brain Tumor Radiotherapy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain neoplasm
    Investigated Drugs:
    • Lithium Sulphate, Anhydrous
    Denmark Sweden

  • Safety Study of 5-Aminolevulinic Acid for Brain Tumor Surgery in Children and Adolescents

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    Investigated Drugs:
    • Aminolevulinic Acid Hydrochloride
    Germany The Netherlands

  • Study of Nivolumab with Chemotherapy for Children and Teenagers with Refractory or Relapsing Solid Tumors or Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    • Ependymoma
    • Rhabdomyosarcoma
    Investigated Drugs:
    • Capecitabine
    • Cyclophosphamide
    • Nivolumab
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!